US 11186647
Chimeric antigen receptors targeting BCMA and methods of use thereof
granted A61KA61K2239/29A61K2239/48
Quick answer
US patent 11186647 (Chimeric antigen receptors targeting BCMA and methods of use thereof) held by LEGEND BIOTECH USA INC. expires Mon Nov 25 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- LEGEND BIOTECH USA INC.
- Grant date
- Tue Nov 30 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 25 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 21
- CPC classes
- A61K, A61K2239/29, A61K2239/48, A61K40/11, A61K40/31